Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Epilepsy
•
Neurology
How do you approach use of newer anti-seizure medications for epilepsy patients on DOACs?
Related Questions
What is your typical workup for first time seizure?
Does persistent focal slowing without epileptiform discharges indicate increased seizure risk in patients without significant structural abnormalities?
How do you decide on the treatment target of burst suppression pattern vs seizure cessation for patients with status epilepticus?
Do you typically recommend muscle biopsy to assess for mitochondrial disease in patients with progressive myoclonic epilepsy?
How long do you wait for a patient to be seizure-free before you clear them with regard to operating heavy machinery (i.e., for work)?
What is your approach to weaning phenobarbital and serial EEGs in patients with HIE after their perinatal seizures are under control?
How do you apply the 2HELPS2B score into clinical decision making for determining duration of cEEG testing?
Do you warn patients about suicidal ideation when starting anti-seizure medications?
How does a patient’s BASED score after starting infantile spasms therapy guide your treatment plan?
How are you using CSF cytokine panels in autoimmune encephalitis, if at all?
